Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from 4DMedical Ltd ( (AU:4DX) ) is now available.
4DMedical Limited has issued 1,356,416 fully paid ordinary shares following the exercise of options under its Long Term Incentive Plan. This move, disclosed without the need for a prospectus under the Corporations Act, indicates the company’s compliance with relevant regulations and supports its strategic growth initiatives.
The most recent analyst rating on (AU:4DX) stock is a Hold with a A$2.00 price target. To see the full list of analyst forecasts on 4DMedical Ltd stock, see the AU:4DX Stock Forecast page.
More about 4DMedical Ltd
4DMedical Limited operates in the healthcare industry, focusing on advanced lung imaging technology. The company provides innovative solutions for lung health assessment, with a market focus on improving diagnostic accuracy and patient outcomes.
Average Trading Volume: 7,615,304
Technical Sentiment Signal: Buy
Current Market Cap: A$1.13B
For a thorough assessment of 4DX stock, go to TipRanks’ Stock Analysis page.